COMMUNIQUÉS West-GlobeNewswire

Fedora Pharmaceuticals Expands Scientific Advisory Board with Appointment of Drs. Michael Dudley, Keith Micetich, and Jürgen Bulitta
10/06/2026
Drs. Dudley, Micetich, and Bulitta Join Existing Board of Renowned Infectious Disease Leaders in Common Goal of Advancing Fedora’s Lead Antibiotic Candidate Towards the Clinic EDMONTON, Alberta , June 10, 2026 (GLOBE [...]
Facial Pain Association Celebrates One-Year Anniversary of the Facial Pain Registry
10/06/2026
Registry Marks Milestone with 740 Participants, New Surveys in Development, and Research Proposals Coming This Fall SUWANEE, Ga., June 10, 2026 (GLOBE NEWSWIRE) -- The Facial Pain Association (FPA) is proud to announce [...]
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
10/06/2026
New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. [...]
Medecision Named #1 Care Management, LTSS, and Complex Care Coordination Technology Vendor by Black Book Research in 2026
10/06/2026
Annual State of Payer Digital Technology report recognizes client ratings of payer IT vendors KING OF PRUSSIA, Pa., June 10, 2026 (GLOBE NEWSWIRE) -- Medecision, a healthcare technology company whose unified data [...]
Koi Peptides Launches Research Peptide Wholesale Program for Labs, Resellers, and Biotech R&D
10/06/2026
Cheyenne, WY, June 10, 2026 (GLOBE NEWSWIRE) -- Koi Peptides (Koi Research Labs LLC) has launched a research peptide wholesale program that supplies bulk, research-use-only peptides, with tiered pricing and per-batch [...]
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
10/06/2026
Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025 Raises full-year 2026 [...]
Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026
10/06/2026
“We measure our progress not only by the milestones we reached, but by the capabilities we built to reach the ones still ahead.” Over 6.9 million shares of common stock repurchased since fiscal Q1 2026 Peaks Curative [...]
JenaValve Appoints Matt Bacso as Chief Financial Officer
10/06/2026
IRVINE, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Matt Bacso, as Chief [...]
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
10/06/2026
Key Highlights Record revenue, continued momentum: all-time high $65.3M in FY2025; strongest-ever Q1 2026, carrying into Q2. Record operational momentum: CosmoFarm wholesale distribution and GMP-certified Cana contract [...]
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
10/06/2026
Strong Commercial Momentum Fueled by Demand for Regulatory-Grade Multi-Modal Real-World Data MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or [...]
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10/06/2026
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch [...]
Physician Pay and Productivity Are Moving in Opposite Directions, MGMA Report Finds
10/06/2026
New benchmarks show compensation rising across all specialties in 2025 even as patient visits fell in all 23 core specialties and standard productivity measures declined in most — a disconnect driven by a worsening [...]
Urteste S.A. enrolls the first patient in the Panuri test clinical study
10/06/2026
Urteste S.A. enrolls the first patient in the Panuri test clinical study Gdańsk, Poland – 10 June 2026 – Urteste S.A. (Warsaw Stock Exchange: URT), a company developing innovative technology for the detection of cancer [...]
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
10/06/2026
LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing- [...]
DataFirst, Inc. and Konica Minolta Healthcare Announce Partnership to Deliver Advanced Interoperability and DICOM Routing Solutions for the Healthcare Enterprise
10/06/2026
WAYNE, N.J. and RALEIGH, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- DataFirst and Konica Minolta Healthcare Americas, Inc. today announced the launch of superior interoperability solutions with Exa® PACS|RIS and Exa® [...]
Beacon Biosignals Unifies Brands, Bringing CleveMed and SleepView® Under the Beacon Name
10/06/2026
Beacon expands home sleep diagnostics with EEG-enabled testing through Waveband, building on CleveMed's established clinical and operational foundation. BOSTON, June 10, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today [...]
CONVOCATION A UNE ASSEMBLEE GENERALE EXTRAORDINAIRE D’IBA SA
10/06/2026
- - LUNDI 29 JUIN 2026 A 11H00 - - Cher Actionnaire, Le quorum requis pour la délibération et le vote sur les sujets à l'ordre du jour de l’assemblée générale extraordinaire des actionnaires de la Société qui était [...]
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
10/06/2026
Study using Nexalin’s proprietary DIFS ™ 15 mA 77.5 Hz treatment platform demonstrated rapid, large-magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up Results further validate [...]
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology
10/06/2026
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve- [...]

Pages